Lifecore Biomedical Stock Performance
| LFCR Stock | 6.35 0.09 1.40% |
The company secures a Beta (Market Risk) of -0.38, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Lifecore Biomedical are expected to decrease at a much lower rate. During the bear market, Lifecore Biomedical is likely to outperform the market. Lifecore Biomedical has an expected return of -0.12%. Please make sure to verify Lifecore Biomedical potential upside, and the relationship between the total risk alpha and kurtosis , to decide if Lifecore Biomedical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Lifecore Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's fundamental indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors. ...more
Actual Historical Performance (%)
One Day Return 0.63 | Five Day Return (3.62) | Year To Date Return 0.16 | Ten Year Return (44.72) | All Time Return (49.88) |
1 | Barclays PLC Acquires 21946 Shares of Lifecore Biomedical, Inc. - AmericanBankingNEWS | 02/29/2024 |
2 | Acquisition by Houde Lovas Katrina of 9474 shares of Lifecore Biomedical subject to Rule 16b-3 | 03/18/2024 |
3 | Glancy Prongay Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Lifecore Biomedical, Inc. on Behalf of Investors | 03/28/2024 |
4 | ONGOING INVESTIGATION ALERT The Schall Law Firm Announces it is Investigating Claims Against Lifecore Biomedical, Inc. and Encourages Investors with Losses to C... | 04/01/2024 |
5 | INVESTIGATION ALERT The Schall Law Firm Announces it is Investigating Claims Against Lifecore Biomedical, Inc. and Encourages Investors with Losses to Contact t... | 04/05/2024 |
6 | Do You Believe in the Upside Trajectory of Lifecore Biomedical - Yahoo Finance | 04/10/2024 |
7 | ROSEN, A TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. fka Landec Corporation Investors to Inquire About Securities Class Action Investigation LFCR, ... | 04/11/2024 |
8 | SHAREHOLDER ALERT Pomerantz Law Firm Investigates Claims on Behalf of Investors of Lifecore Biomedical, Inc. LFCR | 04/16/2024 |
9 | What Made White Falcon Hold Lifecore Biomedical | 04/22/2024 |
10 | Discretionary transaction by Kiper Christopher S of 105110 shares of Lifecore Biomedical subject to Rule 16b-3 | 04/26/2024 |
11 | How To Trade - Stock Traders Daily | 05/02/2024 |
| Begin Period Cash Flow | 1.3 M | |
| Total Cashflows From Investing Activities | -4.2 M |
Lifecore |
Lifecore Biomedical Relative Risk vs. Return Landscape
If you would invest 753.00 in Lifecore Biomedical on February 3, 2024 and sell it today you would lose (118.00) from holding Lifecore Biomedical or give up 15.67% of portfolio value over 90 days. Lifecore Biomedical is currently does not generate positive expected returns and assumes 5.2087% risk (volatility on return distribution) over the 90 days horizon. In different words, 46% of stocks are less volatile than Lifecore, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Lifecore Biomedical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lifecore Biomedical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Lifecore Biomedical, and traders can use it to determine the average amount a Lifecore Biomedical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0229
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LFCR |
Estimated Market Risk
| 5.21 actual daily | 46 54% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Lifecore Biomedical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lifecore Biomedical by adding Lifecore Biomedical to a well-diversified portfolio.
Lifecore Biomedical Fundamentals Growth
Lifecore Stock prices reflect investors' perceptions of the future prospects and financial health of Lifecore Biomedical, and Lifecore Biomedical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Lifecore Stock performance.
| Return On Equity | -1.05 | ||||
| Return On Asset | -0.0467 | ||||
| Profit Margin | (0.96) % | ||||
| Operating Margin | (0.08) % | ||||
| Current Valuation | 391.72 M | ||||
| Shares Outstanding | 30.55 M | ||||
| Price To Book | 1.57 X | ||||
| Price To Sales | 1.79 X | ||||
| Revenue | 185.79 M | ||||
| Gross Profit | 27.29 M | ||||
| EBITDA | 21.25 M | ||||
| Net Income | (97.24 M) | ||||
| Total Debt | 153.09 M | ||||
| Book Value Per Share | (0.14) X | ||||
| Cash Flow From Operations | (24.4 M) | ||||
| Earnings Per Share | (2.14) X | ||||
| Market Capitalization | 193.97 M | ||||
| Total Asset | 295.44 M | ||||
| Retained Earnings | (58.66 M) | ||||
| Working Capital | 60.48 M | ||||
About Lifecore Biomedical Performance
To evaluate Lifecore Biomedical Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Lifecore Biomedical generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Lifecore Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Lifecore Biomedical market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Lifecore's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 24.33 | 42.89 | |
| Return On Tangible Assets | (0.02) | (0.02) | |
| Return On Capital Employed | 0.02 | 0.01 | |
| Return On Assets | (0.01) | (0.01) | |
| Return On Equity | (0.03) | (0.03) |
Things to note about Lifecore Biomedical performance evaluation
Checking the ongoing alerts about Lifecore Biomedical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Lifecore Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Lifecore Biomedical generated a negative expected return over the last 90 days | |
| Lifecore Biomedical has high historical volatility and very poor performance | |
| Lifecore Biomedical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 185.79 M. Net Loss for the year was (97.24 M) with profit before overhead, payroll, taxes, and interest of 27.29 M. | |
| Lifecore Biomedical generates negative cash flow from operations | |
| About 75.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: How To Trade - Stock Traders Daily |
- Analyzing Lifecore Biomedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lifecore Biomedical's stock is overvalued or undervalued compared to its peers.
- Examining Lifecore Biomedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Lifecore Biomedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lifecore Biomedical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Lifecore Biomedical's stock. These opinions can provide insight into Lifecore Biomedical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifecore Biomedical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Lifecore Stock, please use our How to Invest in Lifecore Biomedical guide.Note that the Lifecore Biomedical information on this page should be used as a complementary analysis to other Lifecore Biomedical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Lifecore Stock analysis
When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is Lifecore Biomedical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lifecore Biomedical. If investors know Lifecore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lifecore Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.14) | Revenue Per Share 3.447 | Quarterly Revenue Growth 0.208 | Return On Assets (0.05) | Return On Equity (1.05) |
The market value of Lifecore Biomedical is measured differently than its book value, which is the value of Lifecore that is recorded on the company's balance sheet. Investors also form their own opinion of Lifecore Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Lifecore Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lifecore Biomedical's market value can be influenced by many factors that don't directly affect Lifecore Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lifecore Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lifecore Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lifecore Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.